WESTPORT, CT / ACCESS Newswire / April 9, 2025 / CYduct Diagnostics, Inc. (OTCPK:CYDX) ("CYduct", or the "Company"), a precision medicine-based women's health company focused on the development of breast cancer risk assessment test and diagnostic tools, today announced it is expanding its patient study research on targeted breast cancer biomarkers for risk assessment leading to early detection. A new study directed by CYduct... Read More

Westport, Connecticut--(Newsfile Corp. - May 22, 2024) - CYduct Diagnostics (OTC Pink: CYDX), CYductDX is a disruptive clinical-stage diagnostic company led by an experienced team of senior executives and scientists focused on proprietary technologies for the early assessment and detection of Breast Cancer., will be attending The Reg A & Crowdfunding Conference , which will take place on June 20 at the Westchester Country... Read More

Yale Innovation Summit, May 29-30, New Haven, CT. WESTPORT, CT / ACCESSWIRE / May 16, 2024 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) ("CYduct", "CYductDX", or the "Company"), an innovator in precision breast health enabled by non-invasive intraductal platforms, today announced it is pleased to present at the 2024 Yale Innovation Summit, being held from May 29-30 in New Haven, CT. The 10th annual event will feature... Read More

WESTPORT, CT / ACCESSWIRE / April 2, 2024 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) ("CYduct", or the "Company"), a precision medicine-based women's health company focused on the development of breast cancer risk assessment and diagnostic tools, today announced positive results from its recent research on breast cancer biomarkers. The pilot study, utilizing liquid biopsy samples, met its primary endpoint of measuring... Read More

WESTPORT, CT / ACCESSWIRE / October 31, 2023 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) ("CYduct" or the "Company"), CYduct Diagnostics Inc. , a leading medical device company committed to revolutionizing women's healthcare, is pleased to announce its wholehearted support for the "Find It Early Act," a critical piece of legislation introduced by Congresswoman Rosa DeLauro (CT-03), Congressman Brian Fitzpatrick (PA-01) , and... Read More

WESTPORT, CT / ACCESSWIRE / October 19, 2023 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) ("CYduct" or the "Company"), CYduct Diagnostics Inc., a leading medical device company committed to revolutionizing women's healthcare, with a primary focus on breast health and wellness, is highlighting the critical significance of Breast Cancer Awareness Month. At CYduct Diagnostics Inc., we are dedicated to pioneering new testing... Read More

WESTPORT, CT / ACCESSWIRE / August 1, 2023 / CYduct Diagnostics, Inc. (OTCPK:CYDX) ("CYduct" or the "Company"), - CYduct Diagnostics an emerging force in women's breast health would like to recognize the immeasurable impact that Dr. Susan Love, a visionary leader in defining solutions for breast disease had on our company. Dr. Susan Love, who recently passed, had an untiring dedication to advancing medical diagnostics and... Read More

WESTPORT, CT / ACCESSWIRE / June 28, 2023 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) ("CYduct" or the "Company") - CYduct Diagnostics, a leading provider of innovative diagnostic solutions, is proud to announce its sponsorship of the recent Dr. Susan Love Foundation for Breast Cancer Research's 15th Annual Walk with Love, held on Sunday, June 11, 2023. The event was organized to support the Foundation's mission to end breast... Read More

WESTPORT, CT / ACCESSWIRE / June 8, 2023 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) ("CYduct" or the "Company"), a company focused on developing life-enhancing breast healthcare products is delighted to announce its sponsorship of Camp Breastie 2023, organized by The Breasties, the groundbreaking nonprofit organization that fosters a sense of community for survivors, previvors, thrivers, and carevivors of breast cancer. As... Read More

WESTPORT, CT / ACCESSWIRE / May 4, 2023 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) ("CYduct" or the "Company"), a company focused on developing life-enhancing breast healthcare products was recently recognized by U.S. Senator Chris Murphy (D-Conn.) as April's "Innovator of the Month." CYduct is developing for commercialization the first personalized proteomic test for breast cancer risk assessment - B-FIRST™. The Company's... Read More

WESTPORT, CT / ACCESSWIRE / February 22, 2023 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) ("CYduct" or the "Company"), is a company focused on developing life-enhancing breast healthcare products, recently attended the 11th International Symposium on the Human Breast hosted by Dr. Susan Love Foundation for Breast Cancer Research, a highly-regarded event dedicated to advancing the field of breast health. Where its clinical... Read More

WESTPORT, CT / ACCESSWIRE / January 19, 2023 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) ("CYduct" or the "Company"), is a company focused on developing life-enhancing breast healthcare products, and today provides an update on its corporate guidance outlook for 2023. The Company's corporate strategy remains focused on maximizing performance of its current products and its new breast healthcare product candidates, while... Read More